We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Sleep Disturbances and Pulmonary Artery/Aorta Diameter in Scleroderma Patient (Scleroderma)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00566137
First Posted: December 3, 2007
Last Update Posted: March 9, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Northwell Health
  Purpose
To determine sleep disturbance, pulmonary function test, 6 minute walk, echocardiogram abnormality, arterial blood gas, ventilation/perfusion scan of the chest in Scleroderma patient with Pulmonary Hypertension.

Condition
Scleroderma Pulmonary Hypertension

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Sleep Disturbances and Pulmonary Artery/Aorta Diameter in Scleroderma Patient

Resource links provided by NLM:


Further study details as provided by Northwell Health:

Enrollment: 50
Study Start Date: February 2006
Study Completion Date: February 2007
Detailed Description:
As above
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Males, Females and Minorities

Age range of subjects 18-75 years old

Criteria

Inclusion Criteria:

  • Patient must have Scleroderma

Exclusion Criteria:

  • Patients who do not have Scleroderma
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00566137


Sponsors and Collaborators
Northwell Health
Investigators
Principal Investigator: Arunabh Talwar, MD Northwell Health
  More Information

Responsible Party: ARUNABH TALWAR MD, NORTH SHORE- LONG ISLAND HEALTH SYSTEM
ClinicalTrials.gov Identifier: NCT00566137     History of Changes
Other Study ID Numbers: 06-08-018
NS-LIJHS IRB #06-08-018
First Submitted: November 29, 2007
First Posted: December 3, 2007
Last Update Posted: March 9, 2010
Last Verified: March 2010

Keywords provided by Northwell Health:
Scleroderma
Pulmonary Hypertension

Additional relevant MeSH terms:
Scleroderma, Systemic
Scleroderma, Diffuse
Scleroderma, Localized
Hypertension
Hypertension, Pulmonary
Dyssomnias
Sleep Wake Disorders
Parasomnias
Vascular Diseases
Cardiovascular Diseases
Lung Diseases
Respiratory Tract Diseases
Connective Tissue Diseases
Skin Diseases
Nervous System Diseases
Mental Disorders
Neurologic Manifestations
Signs and Symptoms